SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-063814
Filing Date
2021-05-10
Accepted
2021-05-10 16:01:22
Documents
1
Period of Report
2021-05-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2115776-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2115776-1_4seq1.xml 4 4315
  Complete submission text file 0001104659-21-063814.txt   5848
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16 KANFEY NESHARIM ST. RAMAT GAN L3 5235716
Business Address
Fatal Sigal (Reporting) CIK: 0001850994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38807 | Film No.: 21906960